Enhanced chemiluminescence response of polymorphonuclear leukocytes by new quinolone antimicrobials

Chemotherapy

Volumn 40, Issue 5, 1994, Pages 333-336

  Kubo, Shuta ^a   Matsumoto, Tetsuro ^a   Takahashi, Koichi ^a   Haraoka, Masashi ^a   Tanaka, Masatoshi ^a   Sakumoto, Misao ^a   Sakamoto, Yasuki ^a   Kumazawa, Joichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemiluminescence; Fleroxacin; Ofloxacin; Ouinolones; Polymorphonuclear leukocyte

Indexed keywords

6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID; 7 (2 AMINOMETHYL 4 MORPHOLINYL) 1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; BALOFLOXACIN; FLEROXACIN; GATIFLOXACIN; LOMEFLOXACIN; LUMINOL; OFLOXACIN; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; CHEMILUMINESCENCE; COMPARATIVE STUDY; FLEROXACIN; HUMAN; NEUTROPHILS; OFLOXACIN;

EID: 0028093148     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239215     Document Type: Article

References (16)

1. Easmon CSF, Cole PJ, Williams AJ, Hasti M: The measurement of opsonic and phagocytic function by luminol-dependent chemilumines-cencc. Immunology 1980; 41: 67-74.
2. Dumas R, Brouland JP, Tedone R, Dcscotes J: Influence of macrolide antibiotics on the chemilumines-cence of zymosan-activated human neutrophils. Chemotherapy 1990; 36: 381-384.
3. Eliopoulos GM, Eliopoulos CT: Quinolone antimicrobial agents: Activity in vitro; in Wolfson JS, Hooper DC (eds): Quinolone Antimicrobial Agents. Washington, American Society for Microbiology, 1989, pp 35-70.
4. Hirai K, Aoyama H, Hosaka M, Omori Y, Niwata Y, Suzue S, Irikura T: In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. Antimicrob Agents Chemother 1986; 29: 1059-1066.
5. Sato K, Matsuura Y, Inoue M, Osada Y, Ogawa H, Mitsuhashi S: In vitro and in vivo activity of DL-8280. a new oxazine derivative. Antimicrob Agents Chemother 1982; 22: 548-553.
6. Hirose T, Okezaki E, Kato H, Ito Y, Inoue M, Mitsuhashi S: In vitro and in vivo activity of NY-198, a new difluorinatcd quinolone. Antimicrob Agents Chemother 1987; 31: 854-859.
7. Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K: In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36: 2108-2117.
8. Masakuni O, Masato M, Yoshifumi T, Kiyoshi K, Kenji K, Masahiko K, Masahiro K, Kazuo S, Masako O, Takeshi N: In vitro antibacterial activity of a new quinolone. NM394. Antimicrob Agents Chemother 1991; 35: 2490-2495.
9. Nakamura S et al: In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother 1989; 33: 1107.
10. Ito T, Otsuka M, Nishino T: In vitro antibacterial activity of Q-35, a new fluoroquinolone. Antimicrob Agents Chemother 1992; 36: 1708-1714.
11. Nakajima M, Uematsu T: Pharmacokinetics and safety of Y-26611, a novel quinolone derivative, in healthy volunteers. 31st Intersci Conf Antimicrob Agents Chemother, Chicago, 1991.
12. Muratani T, Inoue M, Mitsuhashi S: In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother 1992; 36: 2293-2303.
13. Koga H: High-performance liquid chromatography measurement of antimicrobial concentration in polymorphonuclear leukocytes. Antimicrob Agents Chemother 1987; 31: 1904-1908.
14. Matsumoto T, Takahashi K, Mizunoe Y, Ogata N, Tanaka M, Kumazawa J, Nozaki M, van der Auvera P: Inhibition of chemiluminescence response of human polymorphonuclear leukocytes by hyperosmolality comparable renal medulla and preservation by ofloxacin. Eur Urol 1991; 20: 232-237.
15. Matsumto T, Takahashi K, Kubo S, Haraoka M, Tanaka M, Mizunoe Y, Ogata N, Kumazawa J: Preservation of chemiluminescence of human leukocytes subjected to hyperosmolality by ofloxacin and DR-3355. Int J Exp Clin Chemother 1991; 4: 125-131.
16. Nagafuji T, Matsumoto T, Takahashi K, Kubo S, Haraoka M, Tanaka M, Ogata N, Kumazawa J: Enhancement of superoxide production of polymorphonuclear neutrophils by ofloxacin and the effect of the inhibitors of protein kinase C. Chemotherapy 1993; 39: 70-76.